bpc 157 tendon to bone healing animal studies BPC-157 - 5MG/10MG TB 500 vs BPC 157:

Common dosing protocols range from 250 to 500 mcg once or twice daily , administered either subcutaneously or intramuscularly

Follow institutional protocols or product labeling for guidance on maximum duration of use after opening (typically ranging from hours to days depending on clinical setting and protocol)

or a femoral neck BMD T-score less than or equal to -2.5 with or without evidence of an existing vertebral fracture(s)

According to FAQs [284] published by the Joint Commission in response to the question, What are the Joint Commission's expectations for managing multi-dose vials of sterile, injectable medication?, multiple-dose vials are labeled as such by the manufacturer and typically contain an antimicrobial preservative to help prevent the growth of bacteria